Yu J, Kiss Z, Ma W, Liang R, Li T
Cancers (Basel). 2025; 17(1.
PMID: 39796653
PMC: 11718887.
DOI: 10.3390/cancers17010022.
Ma M, An J, Jiang T, Xie K
Genes Dis. 2024; 12(2):101353.
PMID: 39717718
PMC: 11665347.
DOI: 10.1016/j.gendis.2024.101353.
Laah A, Tsai P, Yarmishyn A, Ching L, Chen C, Chien Y
Adv Sci (Weinh). 2024; 11(38):e2400370.
PMID: 39113226
PMC: 11481344.
DOI: 10.1002/advs.202400370.
Pulice J, Meyerson M
bioRxiv. 2023; .
PMID: 37994369
PMC: 10664179.
DOI: 10.1101/2023.10.26.563996.
Fazilaty H, Basler K
Nat Genet. 2023; 55(11):1792-1806.
PMID: 37904052
DOI: 10.1038/s41588-023-01526-4.
Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.
Iso H, Hisakane K, Mikami E, Suzuki T, Matsuki S, Atsumi K
Transl Lung Cancer Res. 2023; 12(9):1850-1861.
PMID: 37854151
PMC: 10579824.
DOI: 10.21037/tlcr-23-331.
Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations.
Ding X, Shi W, Han B, Chen H, Li J, An J
Thorac Cancer. 2023; 14(29):2934-2940.
PMID: 37605791
PMC: 10569904.
DOI: 10.1111/1759-7714.15079.
Tissue specificity of oncogenic BRAF targeted to lung and thyroid through a shared lineage factor.
Schoultz E, Liang S, Carlsson T, Filges S, Stahlberg A, Fagman H
iScience. 2023; 26(7):107071.
PMID: 37534159
PMC: 10391731.
DOI: 10.1016/j.isci.2023.107071.
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.
Tomoshige K, Stuart W, Fink-Baldauf I, Ito M, Tsuchiya T, Nagayasu T
Cancer Res. 2023; 83(9):1443-1458.
PMID: 37067057
PMC: 10160002.
DOI: 10.1158/0008-5472.CAN-22-2805.
HDAC3 is critical in tumor development and therapeutic resistance in -mutant non-small cell lung cancer.
Eichner L, Curtis S, Brun S, McGuire C, Gushterova I, Baumgart J
Sci Adv. 2023; 9(11):eadd3243.
PMID: 36930718
PMC: 10022903.
DOI: 10.1126/sciadv.add3243.
An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.
Horie M, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E
Cancer Sci. 2023; 114(6):2596-2608.
PMID: 36840413
PMC: 10236617.
DOI: 10.1111/cas.15764.
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.
Smok-Kalwat J, Mertowska P, Mertowski S, Smolak K, Kozinska A, Koszalka F
Int J Mol Sci. 2023; 24(2).
PMID: 36675020
PMC: 9861992.
DOI: 10.3390/ijms24021506.
Impact of Results of TTF-1 Immunostaining on Efficacy of Platinum-Doublet Chemotherapy in Japanese Patients with Nonsquamous Non-Small-Cell Lung Cancer.
Nakao A, Inoue H, Ikeuchi N, Igata F, Aoyama T, Hamasaki M
J Clin Med. 2023; 12(1).
PMID: 36614938
PMC: 9821382.
DOI: 10.3390/jcm12010137.
Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.
Nakahama K, Kaneda H, Osawa M, Izumi M, Yoshimoto N, Sugimoto A
Thorac Cancer. 2022; 13(16):2309-2317.
PMID: 35808895
PMC: 9376174.
DOI: 10.1111/1759-7714.14560.
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.
Stella G, DAgnano V, Piloni D, Saracino L, Lettieri S, Mariani F
Transl Lung Cancer Res. 2022; 11(3):472-496.
PMID: 35399571
PMC: 8988078.
DOI: 10.21037/tlcr-21-880.
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.
Canals J, Navarro A, Vila C, Canals J, Diaz T, Acosta-Plasencia M
J Exp Clin Cancer Res. 2022; 41(1):37.
PMID: 35081981
PMC: 8790861.
DOI: 10.1186/s13046-021-02206-z.
Thyroid Transcription Factor-1: Structure, Expression, Function and Its Relationship with Disease.
Guan L, Zhao X, Tang L, Chen J, Zhao J, Guo M
Biomed Res Int. 2021; 2021:9957209.
PMID: 34631891
PMC: 8494563.
DOI: 10.1155/2021/9957209.
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
Tanaka I, Dayde D, Tai M, Mori H, Solis L, Tripathi S
J Natl Cancer Inst. 2021; 114(2):290-301.
PMID: 34524427
PMC: 8826620.
DOI: 10.1093/jnci/djab183.
Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
Sano K, Hayashi T, Suehara Y, Hosoya M, Takamochi K, Kohsaka S
J Pathol Clin Res. 2021; 7(4):361-374.
PMID: 34014042
PMC: 8185369.
DOI: 10.1002/cjp2.213.
CRISPRi-mediated functional analysis of NKX2-1-binding sites in the lung.
Stuart W, Fink-Baldauf I, Tomoshige K, Guo M, Maeda Y
Commun Biol. 2021; 4(1):568.
PMID: 33980985
PMC: 8115294.
DOI: 10.1038/s42003-021-02083-4.